14-day Premium Trial Subscription Try For FreeTry Free
$13.48
+0.210 (+1.58%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $12.40 $15.18 Wednesday, 24th Apr 2024 ASMB stock ended at $13.48. This is 1.58% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.30% from a day low at $13.05 to a day high of $13.48.
90 days $0.82 $15.18
52 weeks $0.641 $15.18

Historical Assembly Biosciences prices

Date Open High Low Close Volume
Apr 24, 2024 $13.40 $13.48 $13.05 $13.48 5 632
Apr 23, 2024 $13.22 $13.27 $13.00 $13.27 13 829
Apr 22, 2024 $13.66 $13.66 $13.14 $13.22 7 204
Apr 19, 2024 $13.69 $13.90 $13.24 $13.41 11 270
Apr 18, 2024 $12.95 $13.33 $12.40 $13.33 16 689
Apr 17, 2024 $14.80 $14.80 $12.55 $12.92 26 429
Apr 16, 2024 $14.65 $14.96 $14.35 $14.52 7 400
Apr 15, 2024 $14.66 $15.18 $14.55 $14.93 17 358
Apr 12, 2024 $14.97 $15.00 $14.59 $14.65 19 380
Apr 11, 2024 $14.35 $15.07 $14.35 $15.06 13 918
Apr 10, 2024 $14.78 $14.99 $14.51 $14.68 8 353
Apr 09, 2024 $14.42 $14.99 $14.20 $14.85 26 414
Apr 08, 2024 $14.04 $14.70 $14.04 $14.40 17 966
Apr 05, 2024 $13.64 $14.50 $13.41 $13.77 20 464
Apr 04, 2024 $13.99 $14.23 $13.36 $13.64 26 696
Apr 03, 2024 $13.33 $14.35 $13.26 $13.79 41 050
Apr 02, 2024 $13.15 $13.50 $12.80 $13.50 37 029
Apr 01, 2024 $13.30 $13.30 $12.90 $12.90 18 808
Mar 28, 2024 $13.15 $13.45 $13.02 $13.30 30 110
Mar 27, 2024 $13.13 $13.40 $12.73 $13.38 21 473
Mar 26, 2024 $13.35 $13.40 $12.71 $13.06 19 950
Mar 25, 2024 $12.80 $13.39 $12.66 $13.20 35 651
Mar 22, 2024 $12.37 $12.98 $12.16 $12.98 20 409
Mar 21, 2024 $12.08 $12.69 $12.08 $12.20 21 777
Mar 20, 2024 $11.87 $12.39 $11.87 $12.39 7 165
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT